CASP3 and neoplasm: The administration of recombinant proteins of TRAIL, an apoptosis inducer, and the overexpression of p53, a tumor suppressor, reduced the tumorigenic genes and elevated cleaved caspase 3, an apoptosis marker (Figure 5A,B).